Asia-Pacific Pharmaceutical Plastic Bottles - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

The Asia Pacific Pharmaceutical Plastic Bottles Market size is estimated at USD 2.81 billion in 2024, and is expected to reach USD 3.56 billion by 2029, growing at a CAGR of 4.85% during the forecast period (2024-2029).

Key Highlights

• China's policies to expedite the transformation of its medical regime are anticipated to contribute to the growth of the market for pharmaceutical plastic bottles. Additionally, China is modernizing its pharmaceutical packaging infrastructure and materials and expanding its pharmaceutical plastic bottle range, likely opening up new prospects for pharmaceutical packaging companies. For instance, the Government of China intends to develop a 10-year strategic plan to become a world leader in several high-tech sectors.
• Further, these sectors unexpectedly include biotech, which is not traditionally a vital area of Chinese manufacturing, being more associated with generic production. The government has significantly increased its investments in and promoting biotech to encourage innovation. Currently, biologically advanced output, including cell and gene therapy, is limited in Eastern China, focusing on the US FDA-approved sites in the provinces of Shanghai, Zhejiang, and Jiangsu.
• India is the most populous nation, with 1.4 billion inhabitants and the fifth-largest economy. Due to the well-established pharmaceutical industry, rising investments in the sector, the expanding population, increasing health awareness, and rising life expectancy, the market for plastic bottles for pharmaceutical packaging solutions in India is anticipated to grow significantly.
• The government has imposed stringent rules for using plastic bottles in pharmaceutical packaging. This may be a significant constraint for some time. It has a negative effect on the profit margins of the producers. However, the raw materials used for biodegradability are costly compared to non-biodegradability, increasing the overall production cost. Therefore, increasing cost pressures will also hold back the market growth.

Asia-Pacific Pharmaceutical Plastic Bottles Market Trends

Polyethylene Terephthalate (PET) is Expected to Witness Significant Growth

• Manufacturers prefer PET plastic bottles because they require the least amount of raw material to be processed in the manufacturing process compared to other plastics. Due to its versatility in color and design, PET plastic bottles have become a popular choice among industry players. PET plastic bottles also offer the highest safety and quality, so they are increasingly used in the pharmaceutical industry.
• In addition, PET can reduce the product's weight by up to 90% compared to glass, resulting in a more cost-effective transportation process. PET plastic bottles are replacing the bulky and fragile glass bottles used in the pharmaceutical sector in Asia-Pacific. For instance, as indicated by the PACE and the NCL, it is feasible to transport 30,000 100-ml PET bottles in a single truck, compared to only 18,000 glass bottles. This significantly reduces transportation costs and environmental impact.
• According to the National Bureau of Statistics of China, as of December 2023, China produced roughly 6.98 million metric tons of plastic products every month, compared to 6.39 million metric tons in April 2023.
• The growing availability of plastic products can support the expansion of the pharmaceutical industry in Asia-Pacific. As pharmaceutical companies look to expand their operations and enter new markets, ensuring a stable and ample supply of packaging materials is crucial. This can help pharmaceutical companies meet increasing demand and explore new growth opportunities.

China to Account for Significant Market Growth

• Pharmaceutical plastic bottle businesses in China are expected to have many business opportunities due to the country's robust pharmaceutical sector growth. Additionally, the Chinese government's initiatives to quicken the nation's healthcare system reform are anticipated to encourage the growth of the pharmaceutical plastic bottle business.
• For instance, by the plan for creating the Chinese Pharmacopoeia 2025 Edition, the Chinese Pharmacopoeia Commission published the drafts of 46 pharmaceutical packaging standards in June 2022.
• The aging population, the increasing prevalence of chronic diseases associated with lifestyle choices, the growing public awareness of packaged healthcare benefits, and the growing demand for plastic packaging within the healthcare and pharmaceutical industries are the key drivers of the Chinese plastic pharmaceutical packaging market growth.
• According to the China Center for Disease Control and Prevention (CCDC), 76.35% of China’s population aged 60 or over had at least one chronic disease, while 37.2% had multiple chronic diseases. These factors will drive domestic pharmaceutical production, thus increasing the need for innovative plastic packaging solutions.
• The development of independent research and development teams by China's pharmaceutical plastic bottle companies is encouraged to investigate cutting-edge, environmentally friendly, secure, helpful, and sustainable packaging materials and products. The market value has increased due to the growing innovation, collaboration, acquisition, and production in the drug manufacturing industry.
• According to the National Bureau of Statistics of China, retail trade medicine revenue in China was USD 9.64 billion in December 2023, compared to USD 7.41 billion in April 2023. With the growth in retail trade medicine revenue, pharmaceutical companies may introduce new products or expand their existing product lines.
• Also, this could include medications in various forms and dosages, which would require a range of packaging options, including plastic bottles. The need for diverse packaging solutions can contribute to the growth of the plastic bottles market.

Asia-Pacific Pharmaceutical Plastic Bottles Industry Overview

The Asia-Pacific pharmaceutical plastic bottles market is fragmented, with many players like Amcor Group GmbH, Silgan Holdings Inc., and Chemco Group. These players have adopted various organic and inorganic strategies to dominate the market, such as mergers and acquisitions, partnerships, new product launches, and collaborations.

January 2024: Gerresheimer, a leading provider of systems and solutions for the pharma, biotech, and cosmetics industries, partnered with Aptar Digital Health, a global specialist in Software as a Medical Device (SaMD) and digital Patient Support Programs (PSPs), to jointly create an integrated cancer therapy management solution.

January 2023: Amcor agreed to acquire MDK, based in Shanghai. MDK's yearly sales amount to around USD 50 million, and its primary revenue segment is the supply of medical device packaging, a critical growth area for Amcor. Amcor's leadership position in a broader Asian-Pacific healthcare packaging industry, now consisting of four manufacturing sites offering products to China, India, Japan, and Southeast Asia markets, will be strengthened by adding MDK.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.